Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday

Gainers

  • Senti Biosciences, Inc. (NASDAQ:SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
  • BigBear.ai Holdings, Inc. (NYSE:BBAI) climbed 30.3% to close at $1.55 after the company announced it was awarded a $14.8 million U.S. Army Global Force Information Management system contract.
  • Vertical Aerospace Ltd. (NASDAQ:EVTL) gained 27.2% to close at $9.64.
  • Avalon GloboCare Corp. (NASDAQ:AVCO) gained 25.8% to close at $0.7049. Avalon GloboCare received allowance for joint U.S. Patent.
  • TuanChe Limited (NASDAQ:TC) gained 25.3% to close at $3.07. TuanChe posted a H1 loss of $0.11 per share.
  • Ocular Therapeutix, Inc. (NASDAQ:OCUL) surged 24.2% to close at $5.13 following the company's presentation at the AAO 2022 Annual Meeting.
  • Mill City Ventures III, Ltd. (NASDAQ:MCVT) climbed 23.6% to close at $2.62.
  • HeartBeam, Inc. (NASDAQ:BEAT) surged 21.5% to settle at $4.18 on continued strength after the company on Wednesday announced a patent grant.
  • Sientra, Inc. (NASDAQ:SIEN) gained 21% to close at $0.6096. Sientra recently received regulatory approval to market breast implants in Saudi Arabia.
  • Jupiter Wellness, Inc. (NASDAQ:JUPW) climbed 20.5% to close at $0.7334. Jupiter Wellness announced application for dual listing on upstream.
  • Akouos, Inc. (NASDAQ:AKUS) climbed 16.8% to close at $6.30. William Blair initiated coverage on Akouos with an Outperform rating and announced a price target of $12.
  • Harrow Health, Inc. (NASDAQ:HROW) rose 16.3% to close at $11.52. The FDA approved Harrow Health and Sintetica S.A's Iheezo (chloroprocaine hydrochloride ophthalmic gel) 3% for ocular surface anesthesia.
  • Stryve Foods, Inc. (NASDAQ:SNAX) gained 14.6% to close at $0.52.
  • Cognition Therapeutics, Inc. (NASDAQ:CGTX) gained 13.8% to close at $1.98 after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and $12 price target.
  • Golden Sun Education Group Limited (NASDAQ:GSUN) rose 13.7% to close at $32.40.
  • Tyra Biosciences, Inc. (NASDAQ:TYRA) surged 13.3% to close at $8.78.
  • Immunovant, Inc. (NASDAQ:IMVT) gained 12.3% to close at $5.38. Chardan Capital maintained Immunovant with a Buy and lowered the price target from $14 to $12.
  • SilverSun Technologies, Inc. (NASDAQ:SSNT) rose 11.3% to close at $2.76 after the company announced it entered into a definitive agreement and plan of merger with Rhodium Enterprises.
  • Aditxt, Inc. (NASDAQ:ADTX) shares climbed 10.5% to close at $3.38. Aditxt said it has regained compliance with Nasdaq listing requirements.
  • Motus GI Holdings, Inc. (NASDAQ:MOTS) shares rose 9% to close at $2.55 after the company was recognized as a sole source provider by the Veterans Health Administration.
  • Performance Shipping Inc. (NASDAQ:PSHG) climbed 8.8% to close at $0.2394.
  • BK Technologies Corporation (NYSE:BKTI) rose 8.8% to close at $2.34. BK Technologies received a $1 million purchase order for BKR 5000 from Virginia Department of Forestry.
  • Ero Copper Corp. (NYSE:ERO) gained 7.3% to close at $11.18.
  • Hempacco Co., Inc. (NASDAQ:HPCO) rose 7.1% to close at $2.58. Hempacco recently announced the release of Hemp Hop Smokables on www.HempHop.shop.
  • Marker Therapeutics, Inc. (NASDAQ:MRKR) gained 7% to close at $0.3734.
  • Enerpac Tool Group Corp. (NYSE:EPAC) gained 7% to close at $17.97 following upbeat Q4 results.
  • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) gained 6.2% to close at $3.44. Mind Medicine recently priced a 7.05 million share offering of common shares and warrants at $4.25 per share plus warrants.
  • Windtree Therapeutics, Inc (NASDAQ:WINT) rose 6.2% to close at $0.34 after the company said Istaroxime Phase 2 study in early cardiogenic shock was published in the European Journal of Heart Failure.
  • BioRestorative Therapies, Inc. (NASDAQ:BRTX) gained 5.3% to close at $2.98. Maxim Group initiated coverage on the stock with a Buy rating and $6 price target.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.